✦ LIBER ✦

Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity

✍ Scribed by Sominanda, A; Rot, U; Suoniemi, M; Deisenhammer, F; Hillert, J; Fogdell-Hahn, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNL10 COST-EFFECTIVENESS OF SCREENING FO

✍ F Munschauer; S Rich; DM Huse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Polymorphisms of innate pattern recognit

✍ Enevold, C.; Oturai, A. B.; Sorensen, P. S.; Ryder, L. P.; Koch-Henriksen, N.; B 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 132 KB

Neutralisierende Antikörper gegen Interf

✍ Claudia Gneiss; F. Deisenhammer 📂 Article 📅 2003 🏛 Walter de Gruyter GmbH & Co. KG 🌐 German ⚖ 195 KB

Neutralizing antibodies in multiple scle

✍ Shahkarami, Mohammad Amir; Vaziri, Behrouz; Salami, Shiva; Harandi, Ali Amini; O 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Interferon-beta treatment in multiple sc

✍ Omer Anlar; Temel Tombul; Hanefi Ozbek; Imdat Dilek 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

Bioavailability of Interferon-beta in pa

✍ B. C. Kieseier; H.-P. Hartung 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB